University of Rochester

Dyne Therapeutics came out of stealth mode on April 3 with $50m in Series A venture capital to build out its platform for developing antibody conjugates that deliver nucleic acids and other molecules

IN VITRO DIAGNOSTICS Adarza Biosystems Inc. Adarza Biosystems Inc. raises $5mm in Series B round Adarza Biosystems Inc. raised $5mm in its Series B financing round led by Cultivation Capital,

Device Transactions The medical device industry raised $1.8 billion in financing during the second quarter of 2015 – nearly double the $934 million amassed in Q1. ( See Exhibit 1. ) The increase is at

IN VITRO DIAGNOSTICS Alliances Biohit Oyj Mekalasi Oy Mekalasi Oy agreed to distribute four of Biohit Oyj ’s Quick Tests in Finland. (May) Included in the deal are the Heliobacter Pylori UFT300